Twelve months after two 16 mg doses of the drug, called CYB003, seven patients saw their scores improve on the ...

The Company is currently developing SPC-15 as an intranasal treatment for PTSD SARASOTA, FL, Nov. 18, 2024 (GLOBE NEWSWIRE) - ...

During certain seasons of the year, you may notice changes in your energy level, sleep and interest in activities.

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

Fact checked by Nick Blackmer Key Takeaways Seasonal affective disorder (SAD) affects millions of Americans each year, and ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

'Functional unblinding was a major barrier to the approval of psychedelics as medicines to treat the patients who need them most,' said Dr. Andrew Chadeayne, CaaMTech CEO. 'I'm incredibly proud that ...

The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

As psychedelic medicine inches closer to mainstream acceptance, researchers have tackled a crucial question: How many ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...